Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
NCT01281189 is registered in ClinicalTrials.gov with Knopp Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of the Safety and Efficacy of Dexpramipexole in Subjects With Amyotrophic Lateral Sclerosis
- Lead sponsor
- Knopp Biosciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- November 30, 2012
- Enrollment
- 942 (actual)
- Sites
- 82
Conditions
As the registry lists them; a condition with its own page is linked.